A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer
- Immunity. 2025 Sep 15:S1074-7613(25)00378-4. doi: 10.1016/j.immuni.2025.08.015.
- 1. Mildred Scheel Early Career Centre (MSNZ) for Cancer Research Würzburg, University Hospital Würzburg and University Würzburg, Würzburg, Germany.
- 2. Department of Gynecology and Obstetrics, University Hospital Würzburg, Würzburg, Germany.
- 3. Institute of Pathology, University of Würzburg, Würzburg, Germany.
- 4. Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany.
- 5. Institute of Innate Immunity, Department of Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Bonn, Germany.
- 6. Comprehensive Heart Failure Center, University Hospital Würzburg, Würzburg, Germany.
- 7. Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
- 8. Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany; Department of Microbiology and Immunology, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
- 9. Experimental Systems Immunology, Max Planck Institute of Biochemistry, Martinsried, Germany; Institute of Innate Immunity, Department of Systems Immunology and Proteomics, Medical Faculty, University of Bonn, Bonn, Germany.
- 10. Department of Molecular Oncology and Cancer Biology and Evolution Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
- 11. Mildred Scheel Early Career Centre (MSNZ) for Cancer Research Würzburg, University Hospital Würzburg and University Würzburg, Würzburg, Germany; Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
- 12. Mildred Scheel Early Career Centre (MSNZ) for Cancer Research Würzburg, University Hospital Würzburg and University Würzburg, Würzburg, Germany; Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of Würzburg, Würzburg, Germany. Electronic address: [email protected].
Tumor-draining lymph nodes (TDLNs) are sites of anti-tumor immune priming as well as metastases. Here, we examined how the cellular networks within TDLNs are reorganized in triple-negative breast Cancer (TNBC). We found that the frequencies of programmed death ligand 1 high (PD-L1hi) monocytes increased in TDLNs of metastatic TNBC mouse tumors. Fibroblastic reticular cell (FRC) subtypes heightened the expression of the chemokines CCL2 and CCL7, supporting the homing of CCR2+ monocytes. These monocytes suppressed T cells in vitro via PD-L1 and inducible nitric oxide synthase (iNOS). Spatial transcriptomics revealed immunosuppressive FRC-monocyte niches in vascularized and T cell areas. Tumor-associated Toll-like Receptor (TLR) 4 ligands induced CCL2 and CCL7 expression by FRCs to promote monocyte recruitment. Localized TLR4 inhibition in combination with anti-programmed cell death protein 1 (αPD-1) therapy reduced monocyte homing and boosted T cell function, ultimately attenuating lung metastases. Monocytes accumulate in human TNBC TDLNs, with evidence of a FRC-monocyte axis, and a TLR4 ligand signature is predictive of poor survival outcomes in TNBC patients. Thus, metastatic TNBC can reprogram lymph nodes (LNs) to facilitate PD-L1-mediated immune evasion and metastasis.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: MyD88Research Areas: Cardiovascular Disease